care - Vascularcare.de

7. Dahlman TC: Osteoporotic fractures and the
recurrence of thromboembolism during pregnancy
and the puerperium in 184 women undergoing
thromboprophylaxis with heparin. Am J Obstet
Gynecol 168 (1993) 1265–70
8. Douketis JD, Ginsberg JS, Burrows RF, et al.: The
effects of long-term heparin therapy during pregnancy
on bone density. Thromb Haemost 70 (1996)
254–57
9. Empson MB, Lassere M, Craig JC, Scott JR:
Prevention of recurrent miscarriage for women
with antiphospholipid antibody or lupus
anticoagulant. Cochrane Database of Systematic
Reviews (2005), Issue 2. Art. No.: CD002859. DOI:
10.1002/14651858.CD002859.pub2
10. Fawzy M, Shokeir T, El-Tatongy M, Warda O,
El-Refaiey AA, Mosbah A: Treatment options and
pregnancy outcome in women with idiopathic
recurrent miscarriage: a randomized placebocontrolled
study. Arch Gynecol Obstet 278 (2008)
33–38
11. Flessa HC, Kapstrom AB, Glueck HI, et al.: Placental
transport of heparin. Am J Obstet Gynecol 93
(1965) 570–73
12. Forestier F, Daffos F, Rainaut M, et al.: Low molecular
weight heparin (CY 216) does not cross the
placenta during the third trimester of pregnancy.
Thromb Haemost 57 (1987) 234
13. Franchini M: Haemostasis and pregnancy. Thromb
Haemost 95 (2006) 401–13
14. Ginsberg JS, Hirsh J, Turner CD, et al.: Risks to the
fetus of anticoagulant therapy during pregnancy.
Thromb Haemost 61 (1989) 197–203
15. Ginsberg JS, Kowalchuk G, Hirsh J, et al.: Heparin
therapy during pregnancy: risks to the fetus and
mother. Arch Intern Med 149 (1989) 2233–36
16. Greer IA: Prevention of venous thromboembolism in
pregnancy. Eur J Med Res 9 (2004) 135–45
17. Greer IA, Nelson-Piercy C: Low-molecular-weight
heparins for thromboprophylaxis and treatment of
venous thromboembolism in pregnancy: a systematic
review of safety and efficacy. Blood 106 (2005)
401–7
18. Jacobsen AF, Skjeldestad FE, Sandset PM: Incidence
and risk patterns of venous thromboembolism in
pregnancy and puerperium – a register-based casecontrol
study. Am J Obstet Gynecol 198 (2) (2007)
233.e1–7.
19. James AH, Jamison MG, Brancazio LR, Myers ER:
Venous thromboembolism during pregnancy and
the postpartum period: incidence, risk factors,
and mortality. Am J Obstet Gynecol 194 (2006)
1311–15
20. Kaandorp S, Goddijn M, van der Post J et al.:
Aspirin and Aspirin Combined with Low-Molecular-
Weight Heparin in Women with Unexplained
Recurrent Miscarriage: a Randomized Controlled
Multicenter Trial (ALIFE Study) Blood 114 (2009)
202
21. Laskin CA, Spitzer KA, Clark CA, Crowther MR,
Ginsberg JS, Hawker GA, Kingdom JC, Barrett J,
Gent M: Low Molecular Weight Heparin and Aspirin
for Recurrent Pregnancy Loss: Results from the
Randomized, Controlled HepASA Trial. J Rheumatol
Feb 36(2) (2009) 279–87
22. Mak A, Cheung M, Cheak AA, Chunman Ho R:
Combination of heparin and aspirin is superior to
aspirin alone in enhancing live births in patients
with recurrent pregnancy loss and positive
antiphospholipid antibodies: a meta-analysis of
randomized controlled trials and meta-regression.
Rheumatology 49 (2010) 281–88
23. Mantha S, Bauer KA, Zwicker JI: Low molecular
weight heparin to achieve live birth following
unexplained pregnancy loss: a meta-analysis. Blood
114 (2009) 202
24. RCOG Green-top Guideline No. 28 (2007): Thrombembolic
disease in pregnancy and the puerperium:
acute management. www.rcog.org.uk
25. RCOG Green-top Guideline No. 37 (2009): Thrombosis
and Embolism during Pregnancy and the
Puerperium, Reducing the Risk. www.rcog.org.uk
26. Robertson L, Wu O, Langhorne P, et al.: Thrombophilia
in pregnancy: a systematic review. Br J
Haematol 132(2) (2006) 171–96
27. Rodger M: Thrombophilia and placenta-mediated
pregnancy complications: from the bench to
bedside to policy. Thromb Res 123 Suppl 2 (2009)
S100–S4
28. Schleussner E: Impact of the antiphospholipid syndrome
on complications during pregnancy. Transfus
Med Hemother 33 (2006) 486–94
29. Schleussner E, Fischer T, Thaler C, Bauersachs R for
the ETHIG Investor Group: Successful treatment
of antiphospholipid antibody syndrome during
pregnancy with dalteparin and low dose aspirin.
Thromb Res 123 Suppl 2 (2009) S145
30. Scottish Intercollegiate Guidelines Network.
Prophylaxis of venous thromboembolism. A national
clinical guideline no 36. Edinburgh; SIGN (1999)
31. Visser J, Ulander V, Bloemenkamp K, Kaaja R: A
randomised controlled multicenter study: The effect
of enoxaparin and/or aspirin on prevention of
recurrent miscarriage in women with or without
thrombophilia, HABENOX-study. Intern J Gynecol
Obstet 107 Suppl 2 (2009) S371
32. Warkentin TE, Levine MN, Hirsh J, et al.: Heparin
induced thrombocytopenia in patients treated with
low molecular weight heparin or unfractionated
heparin. N Engl J Med 332 (1994) 1330–35
Korrespondenzadresse
Prof. Dr. med. Ekkehard Schleußner
Klinikum der Friedrich-Schiller-
Universität
Klinik für Frauenheilkunde und
Geburtshilfe
Abteilung Geburtshilfe
Bachstraße 18
07740 Jena
Vascular Care 3/2010 Vol. 20 21